Active Ingredient: THIOTEPA
Proprietary Name: THIOTEPA
Dosage Form; Route of Administration: POWDER; INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Strength: 15MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A216037
Product Number: 001
Approval Date: Dec 26, 2023
Applicant Holder Full Name: KINDOS PHARMACEUTICALS CO LTD
Marketing Status:
Prescription
Patent and Exclusivity Information
Active Ingredient: THIOTEPA
Proprietary Name: THIOTEPA
Dosage Form; Route of Administration: POWDER; INTRACAVITARY, INTRAVENOUS, INTRAVESICAL
Strength: 100MG/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: AP
Application Number: A216037
Product Number: 002
Approval Date: Dec 26, 2023
Applicant Holder Full Name: KINDOS PHARMACEUTICALS CO LTD
Marketing Status:
Prescription
Patent and Exclusivity Information